pubmed-article:17460536 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0038435 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0042402 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0162680 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:17460536 | lifeskim:mentions | umls-concept:C0211492 | lld:lifeskim |
pubmed-article:17460536 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:17460536 | pubmed:dateCreated | 2007-4-26 | lld:pubmed |
pubmed-article:17460536 | pubmed:abstractText | To compare the prognostic ability of the imaging agents 99mTc-sestamibi versus 99mTc-tetrofosmin to predict mortality outcomes in patients with documented coronary artery disease and undergoing vasodilator stress testing. | lld:pubmed |
pubmed-article:17460536 | pubmed:language | eng | lld:pubmed |
pubmed-article:17460536 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17460536 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17460536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17460536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17460536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17460536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17460536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17460536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17460536 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17460536 | pubmed:month | Jun | lld:pubmed |
pubmed-article:17460536 | pubmed:issn | 0143-3636 | lld:pubmed |
pubmed-article:17460536 | pubmed:author | pubmed-author:AdamsGeorge... | lld:pubmed |
pubmed-article:17460536 | pubmed:author | pubmed-author:ShawLinda KLK | lld:pubmed |
pubmed-article:17460536 | pubmed:author | pubmed-author:TuttleRobert... | lld:pubmed |
pubmed-article:17460536 | pubmed:author | pubmed-author:Borges-NetoSa... | lld:pubmed |
pubmed-article:17460536 | pubmed:author | pubmed-author:HansonMichael... | lld:pubmed |
pubmed-article:17460536 | pubmed:author | pubmed-author:PagnanelliRob... | lld:pubmed |
pubmed-article:17460536 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17460536 | pubmed:volume | 28 | lld:pubmed |
pubmed-article:17460536 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17460536 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17460536 | pubmed:pagination | 457-63 | lld:pubmed |
pubmed-article:17460536 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:meshHeading | pubmed-meshheading:17460536... | lld:pubmed |
pubmed-article:17460536 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17460536 | pubmed:articleTitle | Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi. | lld:pubmed |
pubmed-article:17460536 | pubmed:affiliation | Department of Medicine (Cardiology), Duke University Medical Center, Durham, North Carolina 27710, USA. | lld:pubmed |
pubmed-article:17460536 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17460536 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:17460536 | pubmed:publicationType | Comparative Study | lld:pubmed |